| Patents for C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718) |
|---|
| 05/31/2001 | US20010002398 (6S)- or 10 (6R,S)- tetrahydrofolic acid is crystallized in a polar medium with pH of 3.5 or greater and have a purity 98% |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/22/2001 | US6235748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 05/17/2001 | WO2001034614A2 Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 05/08/2001 | CA2046128C Method of purifying ferment-produced riboflavin |
| 05/01/2001 | CA2088665C Methotrexate derivative |
| 04/26/2001 | WO2001028599A1 Isoalloxazine derivatives to neutralize biological contaminants |
| 04/25/2001 | EP1094066A2 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 04/18/2001 | EP1091960A1 Bifunctional antagonists of cytokine-sensitive protein kinase activation cascades and methods for use as anti-inflammatory agents |
| 04/12/2001 | WO1999063939A9 Multibinding inhibitors of cyclooxygenase-2 |
| 04/10/2001 | US6215030 Catalytic reduction of acids, esters and anhydrides to alcohols |
| 04/05/2001 | WO2001023389A2 Certain alkylene diamine-substituted heterocycles |
| 03/29/2001 | WO2001021619A1 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 03/29/2001 | DE19944767A1 N-substituierte 4-Aminopteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel N-substituted 4-Aminopteridine, processes for their preparation and their use as medicaments |
| 03/28/2001 | EP1086696A2 Immunopotentiating and infection protective agent and production thereof |
| 03/28/2001 | EP1086065A4 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1086065A1 Combinatorial synthesis of multibinding libraries |
| 03/28/2001 | EP1085893A1 Phosphodiesterase-v modulator drugs and their uses |
| 03/28/2001 | EP1085891A1 Multibinding inhibitors of topoisomerase |
| 03/28/2001 | EP1085861A1 Inhibitors of nitric oxide synthase |
| 03/28/2001 | EP1085846A2 Multibinding inhibitors of microsomal triglyceride transferase protein |
| 03/28/2001 | EP1085845A2 Multibinding inhibitors of cyclooxygenase-2 |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | CA2393896A1 Pteridinones as kinase inhibitors |
| 03/21/2001 | EP1083920A1 Novel antibacterial compounds |
| 03/21/2001 | EP1083919A1 Novel antiviral compounds |
| 03/21/2001 | EP1083894A1 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 03/21/2001 | CN1063444C Stable crystalline (65)-and (GR)-tetrahydrofolic acid |
| 03/20/2001 | CA2034853C Removal of riboflavin from fermentation suspensions |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | CA2383798A1 Pulmonary delivery for bioconjugation |
| 03/15/2001 | CA2383794A1 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/13/2001 | US6201116 Halide indicators |
| 03/08/2001 | WO1999064047A8 Novel antiviral compounds |
| 03/06/2001 | US6197785 Cardiovascular disorders |
| 02/22/2001 | WO2001012198A1 Remedies for myocardial infarction |
| 02/13/2001 | CA2012876C Use of 5-methyltetrahydrofolic acid and 5-formyltetrahydrofolic acid in the treatment of organic mental disturbances |
| 02/08/2001 | WO2001008684A1 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/31/2001 | CN1282218A Compositions and method for treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 01/23/2001 | US6177280 Ricin inhibitors and methods for use thereof |
| 01/18/2001 | WO2001004121A1 Method for making pure stereoisomers of tetrahydrofolic acid ester salts and tetrahydrofolic acid by fractionated crystallisation of tetrahydrofolic acid ester salts |
| 01/18/2001 | WO2001004120A1 Method for producing by stereospecific hydration tetrahydropterins and optically pure derivatives, in particular tetrahydrofolic acid and its optically pure derivatives |
| 01/18/2001 | WO1999064049A9 Novel antibacterial agents |
| 01/17/2001 | EP1069110A1 Sulfonamide derivatives |
| 01/10/2001 | CN1279683A Method for producing f-methoxy-quinoline carboxylic acids |
| 01/09/2001 | US6172072 Heterocyclically substituted benzamides and their use in fighting diseases |
| 01/03/2001 | CN1278797A Oxo-substituted compouns, process of making, and compositions and methods for inhibiting parp activity |
| 12/20/2000 | CN1277197A Stable crystal salt of 5-methyl tetrahydrofolic acid |
| 12/19/2000 | US6162914 Carried out in the presence of a catalytical amount of a water-soluble pb(ii)-salt. |
| 12/19/2000 | US6162806 Oxygen scavenger |
| 12/13/2000 | CN1276370A Process for preparing anticancer compound, and intermediate |
| 12/12/2000 | US6160116 Sodium salt of (6S)-folinic acid |
| 12/06/2000 | CN1275375A Process for preparation of spraying granule of ovoflavin |
| 11/30/2000 | WO2000071160A1 MEDICINAL COMPOSITIONS CONTAINING ANTI-Fas ANTIBODY |
| 11/30/2000 | CA2373992A1 Medicinal compositions containing anti-fas antibody |
| 11/21/2000 | US6150364 Dissolving needle-shaped riboflavin of a stable modification form in an aqueous mineral acid solution with intermixing, adding active charcoal adosrbent to the solution to adsorb dissolve impurities, filtering, crystallizing the filtrate |
| 11/08/2000 | EP1049694A1 Benzothiadiazoles and derivatives |
| 11/02/2000 | WO2000064484A2 Conjugate having a cleavable linkage for use in a liposome |
| 11/02/2000 | WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 11/02/2000 | EP1048668A2 Process for preparing spray granules containing riboflavin |
| 10/30/2000 | CA2306502A1 Process for preparing spray granules containing riboflavin |
| 10/18/2000 | EP1044975A1 Stable crystalline salts of 5-methyltetrahydrofolic acid |
| 10/18/2000 | EP1044969A2 Processes and intermediates for preparing anti-cancer compounds |
| 10/12/2000 | WO2000059884A1 Pharmaceutically active compounds and methods of use thereof |
| 10/12/2000 | CA2361734A1 Pharmaceutically active compounds and methods of use thereof |
| 10/05/2000 | WO2000058289A1 Halide indicators |
| 10/03/2000 | US6126735 Process for coloring high molecular weight organic material and polycyclic pigments |
| 09/28/2000 | WO2000056738A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 09/28/2000 | CA2367866A1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 09/27/2000 | CN1056845C Purification or riboflavin |
| 09/19/2000 | US6121278 Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity |
| 09/13/2000 | EP1034173A2 Method for producing 8-methoxy-quinoline carboxylic acids |
| 08/22/2000 | CA2187409C Stable crystalline tetrahydrofolic acid salts |
| 08/15/2000 | CA2148671C Stable crystalline (6s)-and (6r)-tetrahydrofolic acid |
| 08/10/2000 | WO2000045800A2 Immunosurpressive effects of pteridine derivatives |
| 08/10/2000 | DE19904812A1 Verfahren zur Herstellung von Folsäure A process for preparing folic acid |
| 08/10/2000 | CA2361561A1 Immunosurpressive effects of pteridine derivatives |
| 08/09/2000 | EP1026166A1 Process for the preparation of folic acid |
| 08/09/2000 | EP1026160A1 Nitrogenous fused-ring compounds, process for the preparation of the same, and drugs |
| 08/02/2000 | EP1022951A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 07/27/2000 | WO2000043013A1 Pharmaceutical compositions for alleviating discomfort |
| 07/27/2000 | WO2000042868A1 Infant formula |
| 07/27/2000 | WO1999064033A9 Phosphodiesterase-v modulator drugs and their uses |
| 07/27/2000 | WO1999063994A9 MULTIBINDING INHIBITORS OF HMG-CoA REDUCTASE |
| 07/27/2000 | CA2627837A1 Pharmaceutical compositions for alleviating discomfort |
| 07/25/2000 | US6093703 Pharmaceutical compositions, containing S-adenosyl-L-methionine salt, 5-methyl-tetrahydrofolic acid and 5-formyltetrahydrofolic acid |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/13/2000 | WO2000040172A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/13/2000 | WO2000025764A3 Compositions for the treatment and prevention of cardiovascular diseases |
| 07/13/2000 | CA2356368A1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 07/11/2000 | US6087351 Method for reducing adenosine levels with a dehydroepiandrosterone and optionally a ubiquinone |
| 07/06/2000 | WO2000039129A1 Immunosuppressive effects of pteridine derivatives |
| 07/05/2000 | EP0755396B1 Stable aqueous folinate solution |
| 07/04/2000 | US6083948 Treating anxiety, depression, and other psychiatric and neurological disorders |
| 06/28/2000 | EP1012145A1 Alkoxy-substituted compounds, methods, and compositions for inhibiting parp activity |
| 06/27/2000 | US6080737 Uveitis remedy |
| 06/21/2000 | EP1009739A2 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |